Status: Recruiting
Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
This is a prospective, single-center, placebo-controlled, non-comparative, phase II study to evaluate the influence of an adjuvant, intravenous therapy with zoledronic acid (single dose) on healing after arthroscopic repair of chronic rotator cuff tears. The study including its financial support was approved by the medical director of the General Accident Insurance Institution (AUVA) , Dr. Roland Frank. Hypothesis to prove: Adjuvant intravenous therapy with zoledronic acid does improve tendon healing after arthroscopic reconstruction of chronic rotator cuff tears compared to a control group without adjuvant therapy with zoledronic acid.,
Participants needed: 80
Trial details
Phase: Phase 2Age: 50-70Biological sex: AllType: InterventionalSponsor: AUVA Traumazentrum Vienna Site UKH MeidlingUpdated: Mar 18, 2024Locations: 1
Eligibility criteria
Age between 50 and 70 years [+4]
Patients younger than 50 or older than 70 years of age [+18]